Neuralace Medical Inc. recently announced that it has started the enrollment of patients in January 2023 for the Axon Therapy and Painful Diabetic Neuropathy (AT-PDN) trial. For More Insights into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback